CoChat

Influence of renin–angiotensin system on serum parathyroid hormone levels in uremic patients

The DOI matches its Crossref record; 25 of the 26 references it cites were found in a registry or an index.

Abstract

Introduction The aim of this study was to investigate the factors influencing serum parathyroid (PTH) levels, including medications for treating chronic kidney disease-mineral and bone metabolism disorder (CKD-MBD) in patients with end-stage renal disease. Methods We enrolled 1,076 patients in nine Japanese facilities who had begun hemodialysis (HD) due to ESRD. We investigated the relationships between intact PTH (iPTH) levels and clinical parameters and medications just prior to beginning HD. Results Significant decreases in serum iPTH levels were seen in males, in the presence of diabetes mellitus (DM), and with administration of renin-angiotensin system inhibitors (RASIs). Significant correlations were found between serum calcium and iPTH levels. In the patients administered RASIs, there was a significant decrease in serum iPTH levels with DM, male gender, and administration of active vitamin D sterols (VDs) compared with those not administered RASIs, although serum-corrected calcium levels were not different. Multiple regression analysis found gender, age, presence of DM, and serum calcium and phosphate levels to be significant contributing factors. In addition, administration of angiotensin II receptor blockers (ARBs) may also be a contributing factor to iPTH levels at the beginning HD (p = 0.050). Conclusions In this study, serum iPTH levels were related to administration of ARBs besides gender, age, the presence of DM and serum calcium levels. Our study suggests that…

Overview

Integrity signals

Registry

Crossref · 10.1007/s10157-011-0534-x

Cites

25 of 25 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Citations

Cites

Show all 25 references

Cited by

See all 17

Metadata

Authors
Koiwa, F., Komukai, D., Hirose, M., Yoshimura, A., Ando, R., Sakaguchi, T., Komatsu, Y., Shinoda, T., Inaguma, D., Joki, N., Nishida, H., Ikeda, M., & Shigematsu, T.
Affiliations
  • SHOWA Medical University Fujigaoka Hospital (JP)
  • Start Treatment & Recovery Centers (US)
Corresponding author
Koiwa, Fumihiko
Venue
Clinical and Experimental Nephrology
Published
2011-09-14
Volume
16
Issue
1
Pages
130-135
ISSN
  • 1342-1751 (ISSN-L)
  • 1437-7799
OpenAlex
W1980709686
Cited by
17
References
26
Citations by year
2026: 1 · 2022: 2 · 2020: 2 · 2017: 1 · 2015: 3 · 2014: 5 · 2013: 3
FWCI
1.98
Type
journal article
Language
en
Open access
closed
Licence
www.springer.com/tdm (tdm)
Locations
  • Clinical and Experimental Nephrology (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Nephrology › Parathyroid Disorders and Treatments
  • Health Sciences › Medicine › Nephrology › Dialysis and Renal Disease Management
  • Health Sciences › Medicine › Nephrology › Renal function and acid-base balance
Keywords
renin-angiotensin system, parathyroid hormone, intact PTH, end-stage renal disease, hemodialysis initiation, renin-angiotensin system inhibitors, angiotensin receptor blockers, chronic kidney disease-mineral and bone disorder, diabetes mellitus, serum calcium, phosphate, uremia
MeSH terms
Adolescent, Adult, Aged, Aged, 80 and over, Calcium, Female, Renal Dialysis, Humans, Kidney Failure, Chronic, Male, Middle Aged, Parathyroid Hormone, Renin-Angiotensin System, Uremia, Vitamin D, Angiotensin Receptor Antagonists

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Influence of renin–angiotensin system on serum parathyroid hormone levels in uremic patients. https://app.cochat.ai/papers/10.1007/s10157-011-0534-x
The paper
Koiwa, F., Komukai, D., Hirose, M., Yoshimura, A., Ando, R., Sakaguchi, T., Komatsu, Y., Shinoda, T., Inaguma, D., Joki, N., Nishida, H., Ikeda, M., & Shigematsu, T. (2012). Influence of renin–angiotensin system on serum parathyroid hormone levels in uremic patients. Clinical and Experimental Nephrology. https://doi.org/10.1007/s10157-011-0534-x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.